NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

A different kind of awareness for Breast Cancer Month

Posted By


Canadian drug policy researcher Alan Cassels observes October as breast cancer awareness month by analyzing the hype of breast cancer drug Herceptin. He writes: “The media pushed the glee meter into the red zone, with words like ‘breakthrough,’ ‘wonder drug,’ and ‘impressive advance,’ overblown, laudatory adjectives that I admonish journalism students to strenuously avoid.”

Cassels concludes his column: “We all want new and better breast cancer treatments, but that doesn’t mean we should allow selective and misleading reports of a drug’s benefits to drain our public health care system of precious dollars, and put suffering patients on a roller coaster of hope and despair.”

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

rebecca farmer

October 5, 2005 at 1:41 pm

Hi, I think you’ve posted on the Think Before You Pink campaign in the past, and I wanted to let you know that the newest phase of the campaign has launched and is available online at This year’s campaign is focused on all the pink ribbon products on the market and asking the companies that sell them to be forthcoming about how much money they actually give to breast cancer, etc.